Minimal clinically important difference on the Motor Examination part of MDS-UPDRS.
暂无分享,去创建一个
Norbert Kovács | Kázmér Karádi | J. Janszky | S. Komoly | N. Kovács | K. Karádi | Sámuel Komoly | József Janszky | P. Ács | Krisztina Horváth | Zsuzsanna Aschermann | Z. Aschermann | Péter Ács | Krisztina Horváth | Gabriella Deli | Éva Balázs | Katalin Takács | É. Balázs | Katalin Takács | Gabriella Deli
[1] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.
[2] Anette Schrag,et al. Minimal clinically important change on the unified Parkinson's disease rating scale , 2006, Movement disorders : official journal of the Movement Disorder Society.
[3] J. Janszky,et al. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease]. , 2014, Ideggyogyaszati szemle.
[4] G. Samsa,et al. Determining Clinically Important Differences in Health Status Measures , 1999, PharmacoEconomics.
[5] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[6] P. Klivényi,et al. [VALIDATION OF THE HUNGARIAN MDS-UPDRS: WHY DO WE NEED A NEW PARKINSON SCALE?]. , 2014, Ideggyogyaszati szemle.
[7] R. Hauser,et al. Determination of minimal clinically important change in early and advanced Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[8] A. Tóth,et al. AZ MDS-UPDRS MAGYAR VALIDÁCIÓJA: MIÉRT SZÜKSÉGES ÚJABB PARKINSON-PONTOZÓSKÁLA? , 2014 .
[9] J. Kállai,et al. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease. , 2012, Parkinsonism & related disorders.
[10] P. Patil,et al. Caregiver burden in patients with Parkinson disease undergoing deep brain stimulation: an exploratory analysis. , 2014, Journal of Parkinson's disease.
[11] G. Stebbins,et al. Vibration therapy for Parkinson's disease: Charcot's studies revisited. , 2012, Journal of Parkinson's disease.
[12] S. Targum,et al. The clinical global impressions scale: applying a research tool in clinical practice. , 2007, Psychiatry (Edgmont (Pa. : Township)).
[13] W. Poewe,et al. Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release , 2014, Parkinson's disease.
[14] Ryan P. Duncan,et al. Randomized Controlled Trial of Community-Based Dancing to Modify Disease Progression in Parkinson Disease , 2012, Neurorehabilitation and neural repair.
[15] R. Hays,et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.
[16] G. Stebbins,et al. Assessing the non‐motor symptoms of Parkinson's disease: MDS‐UPDRS and NMS Scale , 2015, European journal of neurology.
[17] János Kállai,et al. Neurokognitív zavarok diagnosztizálási és kezelési lehetőségei Parkinson-kórban , 2015 .
[18] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.
[19] J. Kállai,et al. Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease , 2015, Behavioural neurology.
[20] P. Patil,et al. The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. , 2013, Parkinsonism & related disorders.
[21] Bente R Jensen,et al. Improved clinical status, quality of life, and walking capacity in Parkinson's disease after body weight-supported high-intensity locomotor training. , 2013, Archives of physical medicine and rehabilitation.
[22] T. Dóczi,et al. Bilateral Subthalamic Stimulation can Improve Sleep Quality in Parkinson's Disease. , 2015, Journal of Parkinson's disease.
[23] Jacob Cohen. Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.
[24] P. Buck,et al. Scales for Assessing Nonmotor Symptom Severity Changes in Parkinson's Disease Patients With Symptom Fluctuations , 2010, The International journal of neuroscience.
[25] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[26] Carmen Rodriguez-Blazquez,et al. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. , 2013, Parkinsonism & related disorders.
[27] W. Weiner,et al. The clinically important difference on the unified Parkinson's disease rating scale. , 2010, Archives of neurology.
[28] T. Foltynie,et al. Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease. , 2014, Journal of Parkinson's disease.
[29] S. Fereshtehnejad,et al. Tango for treatment of motor and non-motor manifestations in Parkinson's disease: a randomized control study. , 2015, Complementary therapies in medicine.
[30] M. Gluck. Cognitive Disorders in Parkinson's Disease , 2012 .
[31] Anthony E. Lang,et al. Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments , 2013, Movement disorders : official journal of the Movement Disorder Society.
[32] M. Bergner. Measurement of health status. , 1985, Medical care.
[33] W. Poewe,et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.